Injectable Imiglucerase Instructions for Use

Injectable Imiglucerase Instructions for Use, for the long-term enzyme replacement therapy of patients with non-neuropathic (type I) and chronic neuropathic (type III) Gaucher disease who have significant non-neurological disease manifestations.


File format
PDF
Published
30 October, 2023
Updated
30 October, 2023
MD5 checksum
33A785F594715A4ACF2CDE42A91899C7
Download PDF

Also Manuals